The radiology department of the National Institutes of Health Clinical Center is seeking Cooperative Research and Development Agreements (CRADAs) with one or more medical equipment manufacturers. The CRADAs, which enable the NIHCC and companies to
The radiology department of the National Institutes of Health Clinical Center is seeking Cooperative Research and Development Agreements (CRADAs) with one or more medical equipment manufacturers. The CRADAs, which enable the NIHCC and companies to collaborate on research projects, cover MRI, MR spectroscopy, molecular imaging, image processing, and image-guided surgery.
The objective of the project is the rapid publication of research findings and the timely commercialization of improved diagnostic and treatment strategies. Particular emphasis is placed on discoveries that enhance clinical research, according to the NIHCC. While the NIHCC does not contribute funding, the center can offer collaborators access to facilities, staff, materials, and expertise.
Collaborators can also elect an option to be an exclusive or nonexclusive licensee to government intellectual property rights arising under the CRADA and may qualify as a co-inventor of new technology that is developed under the agreement. For more information, contact Steve Galen at 301/594-4509. Statements of interest must be received by Dec. 10, with formal proposals due 30 days later.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.